CareTrust REIT, Inc. CTRE
No target with a reported result yet
Releases of the last 3 yearsThe numbers CTRE said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| Diluted EPS Fiscal 2026 |
Given $1.45 to $1.50 release Feb 12, 2026
Raised $1.49 to $1.53 release May 7, 2026
Raised $1.53 to $1.56 release Aug 6, 2026
Lowered $1.50 to $1.51 release Nov 5, 2026
|
– | Not reported yet | |
The company's wordsThe Company provided guidance for 2026, projecting net income attributable to CareTrust of approximately $1.45 to $1.50 per share, Normalized FFO of approximately $1.90 to $1.95 per share, and Normalized FAD of approximately $1.90 to $1.95 per share. release Feb 12, 2026 The Company provided updated guidance for 2026, projecting net income attributable to CareTrust of approximately $1.49 to $1.53 per share, Normalized FFO of approximately $2.00 to $2.04 per share, and Normalized FAD of approximately $1.98 to $2.02 per share. release May 7, 2026 The Company provided updated guidance for 2026, projecting net income attributable to CareTrust of approximately $1.53 to $1.56 per share, Normalized FFO of approximately $2.03 to $2.06 per share, and Normalized FAD of approximately $2.01 to $2.04 per share. release Aug 6, 2026 The Company increased its 2026 guidance midpoints, raising the low end of its Normalized FFO and Normalized FAD estimates, and now projects net income attributable to CareTrust of approximately $1.50 to $1.51 per share, Normalized FFO of approximately $2.08 to $2.09 per share, and Normalized FAD of approximately $2.04 to $2.05 per share. release Nov 5, 2026 | ||||
| FFO per share (company-defined) Fiscal 2026 |
Given $1.90 to $1.95 release Feb 12, 2026
Raised $2.00 to $2.04 release May 7, 2026
Raised $2.03 to $2.06 release Aug 6, 2026
Raised $2.08 to $2.09 release Nov 5, 2026
|
– | No standard number | |
The company's wordsThe Company provided guidance for 2026, projecting net income attributable to CareTrust of approximately $1.45 to $1.50 per share, Normalized FFO of approximately $1.90 to $1.95 per share, and Normalized FAD of approximately $1.90 to $1.95 per share. release Feb 12, 2026 Increased 2026 Guidance … The Company provided updated guidance for 2026, projecting net income attributable to CareTrust of approximately $1.49 to $1.53 per share, Normalized FFO of approximately $2.00 to $2.04 per share, and Normalized FAD of approximately $1.98 to $2.02 per share. release May 7, 2026 Increased 2026 Guidance … The Company provided updated guidance for 2026, projecting net income attributable to CareTrust of approximately $1.53 to $1.56 per share, Normalized FFO of approximately $2.03 to $2.06 per share, and Normalized FAD of approximately $2.01 to $2.04 per share. release Aug 6, 2026 Updated 2026 Guidance … The Company increased its 2026 guidance midpoints, raising the low end of its Normalized FFO and Normalized FAD estimates, and now projects net income attributable to CareTrust of approximately $1.50 to $1.51 per share, Normalized FFO of approximately $2.08 to $2.09 per share, and Normalized FAD of approximately $2.04 to $2.05 per share. release Nov 5, 2026 | ||||
| FFO per share (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $1.68 to $1.72 release Feb 12, 2025
Raised $1.69 to $1.73 release May 1, 2025
Raised $1.77 to $1.79 release Aug 6, 2025
Lowered $1.76 to $1.77 release Nov 5, 2025
|
– | No standard number | |
The company's wordsThe Company issued guidance for 2025, with Mr. … Wagner projecting on a per- diluted weighted-average common share basis net income of approximately $1.35 to $1.39, normalized FFO of approximately $1.68 to $1.72, and normalized FAD of approximately $1.72 to $1.76. release Feb 12, 2025 The Company increased guidance for 2025, with Mr. … Wagner projecting on a per- diluted weighted-average common share basis net income of approximately $1.36 to $1.40, normalized FFO of approximately $1.69 to $1.73, and normalized FAD of approximately $1.73 to $1.77. release May 1, 2025 The Company increased guidance for 2025, with Mr. … Wagner projecting on a per- diluted weighted-average common share basis net income of approximately $1.43 to $1.45, normalized FFO of approximately $1.77 to $1.79, and normalized FAD of approximately $1.77 to $1.79. release Aug 6, 2025 The Company updated guidance for 2025, with Mr. … Wagner projecting on a per- diluted weighted-average common share basis net income of approximately $1.41 to $1.42, normalized FFO of approximately $1.76 to $1.77, and normalized FAD of approximately $1.76 to $1.77. release Nov 5, 2025 | ||||
| FFO per share (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $1.43 to $1.45 release Feb 8, 2024
Lowered $1.42 to $1.44 release May 2, 2024
Raised $1.46 to $1.48 release Aug 2, 2024
Raised $1.49 to $1.50 release Oct 29, 2024
|
– | No standard number | |
The company's wordsThe Company issued guidance for 2024, with Mr. … Wagner projecting on a per- diluted weighted-average common share basis net income of approximately $1.02 to $1.04, normalized FFO of approximately $1.43 to $1.45, and normalized FAD of approximately $1.47 to $1.49. release Feb 8, 2024 The Company updated guidance for 2024, with Mr. … Wagner projecting on a per- diluted weighted-average common share basis net income of approximately $1.01 to $1.03, normalized FFO of approximately $1.42 to $1.44, and normalized FAD of approximately $1.46 to $1.48. release May 2, 2024 The Company updated guidance for 2024, with Mr. … Wagner projecting on a per- diluted weighted-average common share basis net income of approximately $0.86 to $0.88, normalized FFO of approximately $1.46 to $1.48, and normalized FAD of approximately $1.50 to $1.52. release Aug 2, 2024 The Company updated guidance for 2024, with Mr. … Wagner projecting on a per- diluted weighted-average common share basis net income of approximately $0.83 to $0.84, normalized FFO of approximately $1.49 to $1.50, and normalized FAD of approximately $1.53 to $1.54. release Oct 29, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-08), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CTRE/export.csv") into a cell.